From: Crystalloids versus colloids for goal-directed fluid therapy in major surgery
 | sDO2Ia, b (mL/kg per minute) | sERa-c (percentage) | mDO2Ib (mm Hg/kg per minute) | Mesent lac (mmol/L) | Arterial Hbb (g/L) | Arterial pH | Arterial pO2 (mm Hg) | Arterial pCO2 (mm Hg) | Arterial BE (mmol/L) |
---|---|---|---|---|---|---|---|---|---|
Restricted Ringer lactate solution (R-RL) | |||||||||
0 minutes | 109 ± 11 | 49 ± 5 | 25 ± 2 | 1.5 ± 0.4 | 101 ± 7 | 7.51 ± 0.02 | 138 ± 9 | 36 ± 2 | 5.4 ± 0.9 |
60 minutes | 103 ± 11 | 48 ± 6 | 26 ± 2 | 1.4 ± 0.6 | 102 ± 6 | 7.51 ± 0.02 | 135 ± 10 | 36 ± 3 | 5.3 ± 1.2 |
180 minutes | 97 ± 12 | 50 ± 6 | 21 ± 2 | 1.2 ± 0.3 | 105 ± 9 | 7.5 ± 0.02 | 134 ± 15 | 36 ± 2 | 4.5 ± 1.7 |
240 minutes | 97 ± 12 | 50 ± 4 | 20 ± 1 | 1.3 ± 0.2 | 104 ± 6 | 7.49 ± 0.04 | 135 ± 12 | 37 ± 2 | 4.3 ± 2.0 |
Goal-directed Ringer lactate solution (GD-RL) | |||||||||
0 minutes | 109 ± 17 | 51 ± 4 | 26 ± 6 | 1.4 ± 0.2 | 100 ± 10 | 7.52 ± 0.05 | 132 ± 11 | 37 ± 3 | 6.3 ± 1.9 |
60 minutes | 116 ± 19 | 50 ± 4 | 30 ± 8 | 1.2 ± 0.2 | 99 ± 10 | 7.52 ± 0.04 | 132 ± 10 | 36 ± 2 | 6.4 ± 2.0 |
180 minutes | 134 ± 26 | 44 ± 4 | 27 ± 6 | 1.2 ± 0.3 | 96 ± 6 | 7.49 ± 0.037 | 127 ± 10 | 38 ± 2 | 5.6 ± 2.0 |
240 minutes | 130 ± 18 | 42 ± 7 | 26 ± 7 | 1.2 ± 0.3 | 90 ± 8 | 49 ± 0.03 | 126 ± 9 | 38 ± 3 | 5.1 ± 2.1 |
Goal-directed colloid solution (GD-C) | |||||||||
0 minutes | 116 ± 18 | 50 ± 6 | 26 ± 6 | 1.4 ± 0.4 | 97 ± 12 | 7.52 ± 0.03 | 135 ± 12 | 37 ± 3 | 5.8 ± 1.2 |
60 minutes | 141 ± 22c | 38 ± 5b, c | 35 ± 8 | 0.9 ± 0.2 | 86 ± 10 | 7.5 ± 0.02 | 132 ± 17 | 38 ± 3 | 5.7 ± 1.4 |
180 minutes | 151 ± 33d | 38 ± 4d, e | 29 ± 6d | 0.8 ± 0.3 | 89 ± 11d | 7.49 ± 0.02 | 131 ± 14 | 38 ± 1 | 5.0 ± 1.3 |
240 minutes | 158 ± 38d | 37 ± 5d | 27 ± 5d | 0.8 ± 0.3 | 87 ± 12d | 7.49 ± 0.02 | 128 ± 16 | 37 ± 1 | 4.6 ± 1.0 |